JP2005524730A5 - - Google Patents

Download PDF

Info

Publication number
JP2005524730A5
JP2005524730A5 JP2004501483A JP2004501483A JP2005524730A5 JP 2005524730 A5 JP2005524730 A5 JP 2005524730A5 JP 2004501483 A JP2004501483 A JP 2004501483A JP 2004501483 A JP2004501483 A JP 2004501483A JP 2005524730 A5 JP2005524730 A5 JP 2005524730A5
Authority
JP
Japan
Prior art keywords
diblock copolymer
valerolactone
polymer
dosage form
polymer block
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004501483A
Other languages
English (en)
Japanese (ja)
Other versions
JP4300184B2 (ja
JP2005524730A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/004368 external-priority patent/WO2003093344A1/en
Publication of JP2005524730A publication Critical patent/JP2005524730A/ja
Publication of JP2005524730A5 publication Critical patent/JP2005524730A5/ja
Application granted granted Critical
Publication of JP4300184B2 publication Critical patent/JP4300184B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004501483A 2002-05-03 2003-04-24 ポリマー性マイクロエマルション Expired - Fee Related JP4300184B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37790102P 2002-05-03 2002-05-03
PCT/EP2003/004368 WO2003093344A1 (en) 2002-05-03 2003-04-24 Polymeric microemulsions

Publications (3)

Publication Number Publication Date
JP2005524730A JP2005524730A (ja) 2005-08-18
JP2005524730A5 true JP2005524730A5 (https=) 2006-06-08
JP4300184B2 JP4300184B2 (ja) 2009-07-22

Family

ID=29401581

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004501483A Expired - Fee Related JP4300184B2 (ja) 2002-05-03 2003-04-24 ポリマー性マイクロエマルション

Country Status (22)

Country Link
US (3) US20060034797A1 (https=)
EP (1) EP1504047B1 (https=)
JP (1) JP4300184B2 (https=)
KR (1) KR20040111466A (https=)
CN (1) CN1290893C (https=)
AR (1) AR039522A1 (https=)
AT (1) ATE380834T1 (https=)
AU (1) AU2003222310B2 (https=)
BR (1) BR0309688A (https=)
CA (1) CA2483282C (https=)
DE (1) DE60318035T2 (https=)
EA (1) EA008244B1 (https=)
ES (1) ES2298510T3 (https=)
IL (1) IL164977A (https=)
MX (1) MXPA04010778A (https=)
MY (1) MY139066A (https=)
NO (1) NO20045283L (https=)
NZ (1) NZ536294A (https=)
PL (1) PL220850B1 (https=)
TW (1) TWI310388B (https=)
WO (1) WO2003093344A1 (https=)
ZA (1) ZA200408854B (https=)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101629B2 (en) * 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
US7638522B2 (en) * 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
KR101140785B1 (ko) * 2002-08-09 2012-05-03 얀센 파마슈티카 엔.브이. 4-〔〔4-〔〔4-（2-시아노에테닐）-2,6-디메틸페닐〕아미노〕-2-피리미디닐〕아미노〕벤조니트릴의 제조방법
WO2004035013A2 (en) * 2002-10-21 2004-04-29 L'oreal Process for dissolving lipophilic compounds, and cosmetic composition
US7968115B2 (en) 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
US8784881B2 (en) 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
JP4929567B2 (ja) * 2004-08-05 2012-05-09 コニカミノルタエムジー株式会社 ポリマーミセル含有製剤の製造方法
KR101381454B1 (ko) * 2004-09-29 2014-04-04 바이엘 인텔렉쳐 프로퍼티 게엠베하 열역학적으로 안정한 형태의 ｂａｙ 43-9006 토실레이트
WO2006042215A1 (en) * 2004-10-08 2006-04-20 Janssen Pharmaceutica, N.V. 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
US7202209B2 (en) * 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
WO2007030680A2 (en) 2005-09-07 2007-03-15 Rigel Pharmaceuticals, Inc. Triazole derivatives useful as axl inhibitors
JP4892264B2 (ja) * 2006-03-30 2012-03-07 高田製薬株式会社 リスペリドン水性液剤
WO2007136134A1 (ja) * 2006-05-23 2007-11-29 Nanocarrier Co., Ltd. 疎水性薬物内包ポリマーミセルの製造方法
KR100795214B1 (ko) * 2006-08-22 2008-01-21 이화여자대학교 산학협력단 온도 민감성 졸-젤 전이 폴리(에틸렌글리콜)/폴리(카보네이트) 블록 공중합체 및 이의 제조방법
AR062927A1 (es) * 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
CA2668748A1 (en) * 2006-11-09 2008-05-15 Bayer Schering Pharma Aktiengesellschaft Polymorph iii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
US20100113533A1 (en) * 2006-11-14 2010-05-06 Bayer Schering Pharma Aktiengesellschaft Polymorph II of 4-[4-(Amino)-3- Fluorophenoxy]-N-Methylpyridine-2-Carboxamide
EP2078010B1 (en) 2006-12-29 2014-01-29 Rigel Pharmaceuticals, Inc. Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
WO2008083353A1 (en) 2006-12-29 2008-07-10 Rigel Pharmaceuticals, Inc. Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
EP2114955B1 (en) 2006-12-29 2013-02-13 Rigel Pharmaceuticals, Inc. Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
ES2672172T3 (es) 2006-12-29 2018-06-12 Rigel Pharmaceuticals, Inc. Triazoles N3-heteroarilsustituidos y triazoles N5-heteroarilsustituidos útiles como inhibidores de Axl
EP2079736B1 (en) 2006-12-29 2017-10-18 Rigel Pharmaceuticals, Inc. Substituted triazoles useful as axl inhibitors
CN101687044B (zh) * 2007-05-25 2014-10-29 不列颠哥伦比亚大学 用于口服给药的治疗剂的制剂和相关方法
FR2919296A1 (fr) * 2007-07-25 2009-01-30 Rhodia Operations Sas Ouverture de cycles epoxy par des carbenes.
WO2009054864A1 (en) 2007-10-26 2009-04-30 Rigel Pharmaceuticals, Inc. Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
CA2730231C (en) 2008-07-09 2016-10-18 Rigel Pharmaceuticals, Inc. Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
US8431594B2 (en) 2008-07-09 2013-04-30 Rigel Pharmaceuticals, Inc. Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors
WO2010072844A1 (en) 2008-12-24 2010-07-01 Tibotec Pharmaceuticals Implantable devices for treating hiv
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
CN101444510B (zh) * 2008-12-31 2011-03-09 南京卡文迪许生物工程技术有限公司 含有伏立康唑的药物制剂及其制备方法
SG172997A1 (en) 2009-01-16 2011-08-29 Rigel Pharmaceuticals Inc Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
CN101531756B (zh) * 2009-04-16 2011-06-15 山东大学 一种水溶性聚乙二醇/聚乳酸多嵌段聚碳酸酯的制备方法
US20100273730A1 (en) * 2009-04-27 2010-10-28 Innopharmax, Inc. Self-emulsifying pharmaceutical compositions of hydrophilic drugs and preparation thereof
NZ624922A (en) 2009-10-01 2016-05-27 Adare Pharmaceuticals Inc Orally administered corticosteroid compositions
WO2011050457A1 (en) 2009-10-26 2011-05-05 The University Of British Columbia Stabilized formulation for oral administration of therapeutic agents and related methods
ES2647614T3 (es) * 2010-12-29 2017-12-22 Medincell Composiciones biodegradables de liberación de fármaco
EP2634179A1 (en) * 2012-02-28 2013-09-04 Sanofi Functional PLA-PEG copolymers, the nanoparticles thereof, their preparation and use for targeted drug delivery and imaging
ITTO20130431A1 (it) * 2013-05-28 2014-11-29 Fond Istituto Italiano Di Tecnologia Copolimero e nanoparticelle da esso ottenute per la veicolazione di un farmaco
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
CN104523592B (zh) * 2015-01-26 2017-03-15 湖北工业大学 甲泼尼龙醋酸酯注射用自微乳制剂及其制备方法
EP4374861A3 (en) 2015-11-16 2024-08-07 MedinCell S.A. A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
EP4137323A1 (en) 2021-08-18 2023-02-22 Imertech Hydraulic binder with low carbon footprint and high early strength
CN117064767A (zh) * 2023-09-05 2023-11-17 深圳市护家科技有限公司 一种肤感优异的水包油组合物、外用皮肤制剂及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058081T3 (es) * 1986-09-05 1994-11-01 American Cyanamid Co Poliesteres que contienen bloques de oxido de alquileno como sistemas de administracion de medicamentos.
US4716203A (en) * 1986-09-05 1987-12-29 American Cyanamid Company Diblock and triblock copolymers
DE3779838T2 (de) * 1986-09-05 1992-12-24 American Cyanamid Co Beschichtung fuer chirurgische faeden.
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
DE4130933A1 (de) * 1991-09-13 1993-03-18 Schering Ag Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln
DE4219536A1 (de) * 1992-06-15 1993-12-16 Herbertz Heinz Verfahren und Zentrifuge zum Entwaessern in Postenwaschanlagen
JP3220331B2 (ja) * 1993-07-20 2001-10-22 エチコン・インコーポレーテツド 非経口投与用の吸収性液体コポリマー類
AU706434B2 (en) * 1994-10-18 1999-06-17 Ethicon Inc. Injectable liquid copolymers for soft tissue repair and augmentation
US6413539B1 (en) * 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US5518774A (en) * 1995-06-26 1996-05-21 Olin Corporation In-can and dry coating antimicrobial
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
KR20000015944A (ko) * 1996-05-24 2000-03-15 팜 윌리암 엔. 신체 통로의 질병을 치료 또는 예방하기 위한조성물 및 방법
WO1998035631A1 (en) * 1997-02-14 1998-08-20 Pathak Chandrashekar Biocompatible polymers and methods for their use
US6211249B1 (en) * 1997-07-11 2001-04-03 Life Medical Sciences, Inc. Polyester polyether block copolymers
IL122933A (en) * 1998-01-14 2005-03-20 Efrat Biopolymers Ltd Polymeric carrier for delivery of a bioactive molecule
HRP20080359B1 (hr) * 1998-11-10 2016-01-01 Janssen Pharmaceutica N.V. PIRIMIDINI KOJI INHIBIRAJU REPLIKACIJU HIV-a
KR100288103B1 (ko) * 1998-12-26 2001-05-02 윤덕용 폴리에테르가 그라프트된 생분해성 지방족 폴리에스테르 및 그의 제조방법
PT1343530E (pt) * 2000-11-09 2007-09-25 Astrazeneca Ab Composição farmacêutica oral contendo um copolímero de blocos
US6617995B2 (en) * 2001-09-24 2003-09-09 Microline Co., Ltd. Radar detector
ATE326679T1 (de) * 2002-01-10 2006-06-15 Davey Bickford Pyrotechnischer elektrischer anzünder und montageverfahren

Similar Documents

Publication Publication Date Title
JP2005524730A5 (https=)
CA2483282A1 (en) Polymeric microemulsions
US9913910B2 (en) Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron
CA2407298A1 (en) Mixtures of triblock polyesterpolyethylene glycol copolymers
CN101155844A (zh) 聚乙二醇-聚缩醛和聚乙二醇-聚缩醛-聚原酸酯接枝共聚物和药物组合物
US20080015210A1 (en) Base-Stabilized Polyorthoester Formulations
WO2007133751A2 (en) Base-stabilized polyorthoester formulations
US20060235084A1 (en) PEG-polyacetal diblock and triblock copolymers and pharmaceutical compositions
CA2601547A1 (en) Peg-poly(ortho ester) graft copolymers and pharmaceutical compositions
WO2014185309A1 (ja) 癒着防止材及びその製造方法
EP2096938A2 (en) Degradable chewing gum
HK40054578A (en) Semi-solid delivery vehicle and pharmaceutical compositions
HK40003214B (en) Semi-solid delivery vehicle and pharmaceutical compositions
HK40003214A (en) Semi-solid delivery vehicle and pharmaceutical compositions
TH76143A (th) สารผสมที่มีการปลดปล่อยแบบเนิ่น, กระบวนการสำหรับการผลิตสารชนิดเดียวกัน และการใช้สารชนิดเดียวกัน
HK1117853A (en) Peg-polyacetal and peg-polyacetal-poe graft copolymers and pharmaceutical compositions
TH77100A (th) สารผสมทางเภสัชกรรม
HK1213477B (en) Semi-solid delivery vehicle and pharmaceutical compositions